Mini reviewPublished 1 Oct 2020
Alveolar-Repairing Effect of 1α,25-Dihydroxyvitamin D3 on Chronic Obstructive Pulmonary Disease Mouse Model Based on Differentiation Inducing: Mini Review
Department of Pharmaceutics and Drug Delivery, Tokyo University of Science, Yamazaki, Noda, Chiba, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic Obstructive Pulmonary Disease (COPD) is the leading cause of death worldwide, but there is no drug to cure completely. We previously reported for the first time in the world the 1α,25-dihydroxyvitamin D3 can improve emphysema in animal COPD model. The aim of this mini review was to describe the effect of 1α,25-dihydroxyvitamin D3 on alveolar regeneration based on differentiation inducing, which we have found. Indicating the usefulness for 1α,25- dihydroxyvitamin D3 in a COPD mouse model that better reflects human medical conditions, 1α,25-dihydroxyvitamin D3 can be expected for drug candidate for novel therapy of COPD.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cardiac and Pulmonary Rehabilitation
- SubjectCardiology
- SubjectPulmonology & Respiratory
- SubjectPhysical Therapy & Rehabilitation
- BylineArticles whose byline prints “Tomomi Akita”
- BylineArticles whose byline prints “Chikamasa Yamashita”